SERDOLECT

This brand name is authorized in Austria, Croatia, Estonia, Finland, Israel, Netherlands, Poland, Romania, Spain, Turkey.

Active ingredients

The drug SERDOLECT contains one active pharmaceutical ingredient (API):

1
UNII GVV4Z879SP - SERTINDOLE
 
Read more about Sertindole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AE03 Sertindole N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1027055, 1027066, 1027077, 1027088, 1064821, 1064832, 1064887, 1064900, 1294343, 1296019, 1296020, 1296042, 1296053, 1296064, 1296075, 1296086, 1296097, 1296109, 1296110, 1296121, 1296132, 1296143, 1296154, 1296165, 1296176, 1296187, 1296198, 1296200, 1296211, 1296222, 1296233, 1296244, 1296255, 1296266, 1296277, 1296288
ES Centro de información online de medicamentos de la AEMPS 61582, 61584, 61585, 61586
FI Lääkealan turvallisuus- ja kehittämiskeskus 405985, 406033, 406165, 406322, 406371, 406389, 406397, 406462
HR Agencija za lijekove i medicinske proizvode HR-H-552440106, HR-H-646463358
IL מִשְׂרַד הַבְּרִיאוּת 6088, 6089
NL Z-Index G-Standaard, PRK 72133, 72141
PL Rejestru Produktów Leczniczych 100128441, 100128458, 100128464
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W44015001, W44015003, W44017001, W44017003
TR İlaç ve Tıbbi Cihaz Kurumu 8699795090574, 8699795090581, 8699795090598, 8699795090604

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.